Trial intelligence / Profile preview

Phase 2 Dose-Finding of CARDIOsphere in Healthy Volunteers and CAD Patients

NCT00584818Phase 2Completed

Sponsor
POINT Biomedical
Start
Nov 2006
Primary completion
Mar 2008
Countries
1
01

Overview

A Phase 2 trial of PB127 in coronary artery disease (CAD), sponsored by POINT Biomedical. Started Nov 2006; status: completed.

02

Drugs

PB127
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00584818.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00584818.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call